Drug Delivery for the Treatment of Children's Cancer
RACI NSW Pharmaceutical Sciences Group
Wednesday 29 September at 10.30 am to 12.00 pm
Presenter: Professor Maria Kavallaris AM
Founding Director, the Australian Centre for NanoMedicine
Head, Translational Cancer Nanomedicine, Children’s Cancer Institute
Children’s cancer is the major
cause of disease related death in developed countries. The primary forms
of treatment include chemotherapy, surgery and in some cases, radiation
therapy. A major cause of death is the development of drug resistance.
Moreover, due to the toxic side effects of current treatments childhood
cancer survivors often experience life-long health issues including
endocrine, cardiac, fertility and learning disorders. There is an urgent
need to develop more effective and specific therapies to reduce the
morbidity and mortality of childhood cancers. Our research has been
focusing on the development of clinically relevant in vitro and in vivo
models of childhood cancer and the development and use of nanoparticle
based delivery systems that have improved efficacy and less toxicity
than conventional therapy.
Speaker : Professor Maria Kavallaris
is recognised for her innovation in driving interdisciplinary research
in cancer nanomedicine. Maria is Chair of the Australian Institute for
Policy and Science, and a Life Member and
past-President of the Australian Society for Medical Research. The
impact of her research has been recognised many times with receipt of
numerous prizes and awards. These include the Australian Museum Eureka Prize, the AFR/Westpac 100 Women of Influence, the 2017 Premiers Science and Engineering Award for Leadership in Innovation in NSW, 2019 Lemberg Medal, and the 2020 NSW Premier's Woman of the Year.
recognised medical research leader, she has been appointed on
government funding panels including NHMRC Research Committee and the
Medical Research Future Fund Stem Cell Therapies Mission Advisory
Committee, where she contributes to high level policy. Maria is a Fellow
of both the Australian Academy of Health & Medical Sciences, and
The Royal Society of New South Wales. In 2019, Maria was appointed a Member (AM) of the Order of Australia for her significant service to medicine, and to medical research, in the field of childhood and adult cancers.
The format of the webinar is that Prof. Kavallaris will give a 45 minute overview, followed by a further Q&A session.
This webinar will be of benefit
and interest to all scientists in medical and nano particle research,
working in both academic and commercial organisations in enhancing
knowledge of cutting-edge technologies. It will also be of significant
interest and benefit to the broader chemists’ community.
Follow the instructions and which
fields to complete as an RACI member or non-member with care. Members
with an RACI account should enter their Username and Password and follow
subsequent instructions. Non-members will initially need to “Create a
new account” and also follow subsequent instructions. Event discount for
members will only apply once they have logged into their account.
A $10 charge will be made for non- RACI members and FREE for members.
Registrations close at 12 noon, Tuesday 28 September.
For any queries on registration, please contact the NSW Branch coordinator, Brent Kooyman, Tuesday to Thursday, 0449766175, email [email protected]